Isolated cutaneous manifestation of COVID-19 managed by telemedicine
DOI:
https://doi.org/10.11606/issn.1679-9836.v101i1e-186624Keywords:
Telemedicine, COVID-19, Pandemics, Urticaria, AngioedemaAbstract
Objectives: This paper is a case report of a COVID-19 patient with a confirmed diagnosis of COVID-19 who had a medical evaluation by Telemedicine (TM). She presented with an isolated cutaneous manifestation and was examined by a remote general practitioner, having diagnosis and treatment guided. The correct evaluation of COVID-19 cutaneous manifestation is a challenge, and the feasibility of TM diagnosis is still uncertain. We aim to demonstrate the effectiveness of teleconsultation in a dermatological manifestation during a pandemic. Material and Methods: Retrospective data compilation from patient’s medical record and the patient signed the consent form. Results: The initial clinical presentation was a diffuse pruritic macules in the abdomen, which motivated the patient to seek face-to-face care in the emergency department on the first day of symptoms. The initial hypothesis was an unspecified allergic reaction. Due to the context of the pandemic, blood tests and RT-PCR (nasopharyngeal swab) were performed for COVID-19. The patient was discharged medicated with an anti allergy and instructed to check the results of the test within 24 hours and have a medical reassessment if necessary. She was re-evaluated by TM the following day, the diagnosis of acute infection by COVID-19 was confirmed (swab positive), there was no manifestation of other symptoms and it was possible to accurately re-evaluate the skin lesions remotely. The patient had a diffuse morbilliform rash with local angioedema. The patient received specific orientations according to institutional guidelines and maintenance of dermatological symptomatic treatment. After 3 weeks, in a new reassessment by TM, there was confirmation of the resolution of the skin condition and absence of other symptoms during this period. Conclusion: The medical evaluation by TM allowed the interpretation of the elementary skin lesion, decision making and adequate guidance. The isolated cutaneous manifestation can be a manifestation of COVID-19 and it is feasible to be diagnosed by teleconsultation, reinforcing the need to expand the MT program for the initial evaluation of acute patients.
Downloads
References
Coronavirus Research Center. Johns Hopkins University and Medicine. 2020. Available at: https://coronavirus.jhu.edu/map.html.
Portnoy J, Waller M, Elliott T. Telemedicine in the Era of COVID-19. J Allergy Clin Immunol Pract. 2020;8(5):1489-91. doi: 10.1016/j.jaip.2020.03.008.
Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. JMIR Public Health Surveill. 2020;6(2):e18810. doi: 10.2196/18810.
Lee JJ, English JC 3rd. Teledermatology: a review and update. Am J Clin Dermatol. 2018;19(2):253-60. doi: 10.1007/s40257-017-0317-6.
Trettel A, Eissing L, Augustin M. Telemedicine in dermatology: findings and experiences worldwide - a systematic literature review. J Eur Acad Dermatol Venereol. 2018;32(2):215-24. doi: 10.1111/jdv.14341.
Edison KE, Ward DS, Dyer JA, Lane W, Chance L, Hicks LL. Diagnosis, diagnostic confidence, and management concordance in live-interactive and store-and-forward teledermatology compared to in-person examination. Telemed J E Health. 2008;14(9):889-95. doi: 10.1089/tmj.2008.0001.
Lim AC, Egerton IB, See A, Shumack SP. Accuracy and reliability of store-and-forward teledermatology: preliminary results from the St George Teledermatology Project. Australas J Dermatol. 2001;42(4):247-51. doi: 10.1046/j.1440-0960.2001.00529.x.
Lamel S, Chambers CJ, Ratnarathorn M, Armstrong AW. Impact of live interactive teledermatology on diagnosis, disease management, and clinical outcomes. Arch Dermatol. 2012;148(1):61-5. doi: 10.1001/archdermatol.2011.1157.
Heffner VA, Lyon VB, Brousseau DC, Holland KE, Yen K. Store-and-forward teledermatology versus in-person visits: a comparison in pediatric teledermatology clinic. J Am Acad Dermatol. 2009;60(6):956-61. doi: 10.1016/j.jaad.2008.11.026.
Gilmour E, Campbell SM, Loane MA, Esmail A, Griffiths CE, Roland MO, et al. Comparison of teleconsultations and face-to-face consultations: preliminary results of a United Kingdom multicentre teledermatology study. Br J Dermatol. 1998;139(1):81-7. doi: 10.1046/j.1365-2133.1998.02318.x.
Lowitt MH, Kessler II, Kauffman CL, Hooper FJ, Siegel E, Burnett JW. Teledermatology and in-person examinations: a comparison of patient and physician perceptions and diagnostic agreement. Arch Dermatol. 1998;134(4):471-6. doi: 10.1001/archderm.134.4.471.
Nami N, Massone C, Rubegni P, Cevenini G, Fimiani M, Hofmann-Wellenhof R. Concordance and time estimation of storeand-forward mobile teledermatology compared to classical face-to-face consultation. Acta Derm Venereol. 2015;95(1):35-9. doi: 10.2340/00015555-1876.
Tang K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q. Cutaneous manifestations of the coronavirus disease 2019 (COVID-19): a brief review. Dermatol Ther. 2020;33(4):e13528. doi: 10.1111/dth.13528.
Young S, Fernandez AP. Skin manifestations of COVID-19. Cleve Clin J Med. 2020. doi: 10.3949/ccjm.87a.ccc031.
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-3. doi: 10.1111/jdv.16387.
Gershon-Cohen J, Cooley AG. Telognosis. Radiology. 1950;55(4):582-7. doi: 10.1148/55.4.582.
Mullick FG, Fontelo P, Pemble C. Telemedicine and telepathology at the Armed Forces Institute of Pathology: history and current mission. Telemed J. 1996;2(3):187-93. doi: 10.1089/tmj.1.1996.2.187.
Whited JD, Hall RP, Simel DL, Foy ME, Stechuchak KM, Drugge RJ, et al. Reliability and accuracy of dermatologists’ clinic-based and digital image consultations. J Am Acad Dermatol. 1999;41(5Pt1):693-702. doi: 10.1016/s0190-9622(99)70003-4.
Rubegni P, Nami N, Cevenini G, Poggiali S, Hofmann-Wellenhof R, Massone C, et al. Geriatric teledermatology: store-and-forward vs. face-to-face examination. J Eur Acad Dermatol Venereol. 2011;25(11):1334-9. doi: 10.1111/j.1468-3083.2011.03986.x.
Romero G, Sanchez P, Garcia M, Cortina P, Vera E, Garrido JA. Randomized controlled trial comparing store-and-forward teledermatology alone and in combination with web-camera videoconferencing. Clin Exp Dermatol. 2010;35(3):311-7. doi: 10.1111/j.1365-2230.2009.03503.x.
Lamel SA, Haldeman KM, Ely H, Kovarik CL, Pak H, Armstrong AW. Application of mobile teledermatology for skin cancer screening. J Am Acad Dermatol. 2012;67(4):576-81. doi: 10.1016/j.jaad.2011.11.957.
Shapiro M, James WD, Kessler R, Lazorik FC, Katz KA, Tam J, et al. Comparison of skin biopsy triage decisions in 49 patients with pigmented lesions and skin neoplasms: store-and-forward teledermatology vs face-to-face dermatology. Arch Dermatol. 2004;140(5):525-8. doi: 10.1001/archderm.140.5.525.
Whited JD, Mills BJ, Hall RP, Drugge RJ, Grichnik JM, Simmel DL. A pilot trial of digital imaging in skin cancer. J Telemed Telecare. 1998;4(2):108-12. doi: 10.1258/1357633981932046.
Ferrandiz L, Moreno-Ramirez D, Nieto-Garcia A, Carrasco R, Moreno-Alvarez P, Galdeano R, et al. Teledermatology-based presurgical management for nonmelanoma skin cancer: a pilot study. Dermatol Surg. 2007;33(9):1092-8. doi: 10.1111/j.1524-4725.2007.33223.x.
Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(6):e244-5. doi: 10.1111/jdv.16472.
Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol. 2020;34(6):e252-4. doi: 10.1111/jdv.16470.
Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, Saceda-Corralo D, Moreno-Garcia Del Real C, et al. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clin Exp Dermatol. 2020;45(7):892-5. doi: 10.1111/ced.14281.
Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246-7. doi: 10.1111/jdv.16471.
Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-5. doi: 10.1016/j.jaad.2020.04.044.
Saenz Aguirre A, De la Torre Gomar FJ, Rosés-Gibert P, Gimeno Castillo J, Martinez de Lagrán Alvarez de Arcaya Z, Gonzalez-Perez R. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain. Clin Exp Dermatol. 2020;45(8):1065-7. doi: 10.1111/ced.14294.
Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020;34(6):e250-1. doi: 10.1111/jdv.16474.
Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID-19: transient livedo reticularis. J Am Acad Dermatol. 2020;83(2):700. doi: 10.1016/j.jaad.2020.04.018.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Mariana Ramos de Santana, Tarso Augusto Duenhas Accorsi, Karine de Amicis Lima, Carlos H. S. Pedrotti, Eduardo Cordioli
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
